Roger Adsett
Chief Operating Officer at INSMED INCORPORATED
Net worth: 4 M $ as of 29/04/2024
Roger Adsett active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INSMED INCORPORATED | Chief Operating Officer | 13/11/2019 | - |
| Corporate Officer/Principal | 26/09/2016 | 13/11/2019 | |
| LANDOS BIOPHARMA, INC. | Director/Board Member | 07/03/2022 | - |
| Independent Dir/Board Member | 07/03/2022 | - |
Career history of Roger Adsett
Former positions of Roger Adsett
| Companies | Position | Start | End |
|---|---|---|---|
| SHIRE | Corporate Officer/Principal | 30/09/2005 | 31/08/2016 |
| ASTRAZENECA PLC | Sales & Marketing | 31/10/1994 | 30/09/2005 |
| Nexium, Inc. | Sales & Marketing | - | - |
| AstraZeneca R & D Lund | Sales & Marketing | - | - |
Training of Roger Adsett
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Bucknell University | Undergraduate Degree |
Statistics
International
| United States | 6 |
| Ireland | 2 |
| Sweden | 2 |
Operational
| Sales & Marketing | 3 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| AstraZeneca R & D Lund | |
| Nexium, Inc. | Finance |
- Stock Market
- Insiders
- Roger Adsett
- Experience
